E Varallyay J Burgyan Z Havelda MicroRNA
J. Burgyan, Z. Havelda, MicroRNA detection by northern blotting
 J. Wan, P.F. Alewood, Peptide-decorated dendrimers and their bioapplications,
teomics approach for mirna quantification via a covalently immobilized DNA-
 F. Degliangeli, P. Kshirsagar, V. Brunetti, P.P. Pompa, R. Fiammengo, Absolute
and direct microRNA quantification using DNA-gold nanoparticle probes,
 Y.W. Tang, D. Persing, Diagnostic Microbiology, Academic Press, Cambridge,
A. Tagliamonte, P. Neri, Synthetic peptides in the form of dendrimers become
Development and application of a sybr green RT-PCR for first line screening
 https://www.promega.com.cn/products/mass spectrometry/proteases-and-
and quantification of porcine sapovirus infection, BMC Vet. Res. 8 (2012)
surfactants/sequencing -grade-modified-trypsin/?catNum¼V5111. (Accessed
in a single cell with droplet digital pcr based on ligation reaction, Anal. Chem.
rolling circle amplification strategy for highly sensitive microRNA detection,
throughput microRNA β-Glycerophosphate profiling from total RNA, Nucleic Acids Res.
detection by DNA-scaffolded silver-nanocluster probe based on isothermal
for Industry: Bioanalytical Method Validation, US Department of Health and
Human Services, Food and Drug Administration, .
molecular beacons for highly sensitive and selective detection of microRNAs
M. Kirby, B. Stouffer, W.G. Humphreys, Liquid chromatography and tandem
based on duplex specific nuclease signal amplification, Chem. Commun. 49
mass spectrometry method for the quantitative determination of saxagliptin
and its major pharmacologically active 5-monohydroxy metabolite in human
plasma: method validation and overcoming specific and non-specific binding,
J. Detmer, L. Shen, A branched DNA signal amplification assay for quantifi-
cation of nucleic acid targets below 100 molecules/ml, Nucleic Acids Res. 25
MicroRNA miR-21 overexpression in human breast cancer is associated with
 J. Li, Z. Li, Dendrimer-supported catalysts for organic synthesis, Curr. Org.
advanced clinical stage, lymph node metastasis and patient poor prognosis,
 M.A. Swiderska, J.L. Reymond, Analytical chemistry: a dendritic signal
Contents lists available at ScienceDirect
An analysis of 11.3 million screening tests examining the association between needle biopsy rates and cancer detection rates in the English NHS Breast Cancer Screening Programme
a Cancer Epidemiology Unit, Nuffield Department of Population Health, Oxford University, Richard Doll Building, Roosevelt Drive, Oxford, OX3 7LF, UK b Department of Radiology, St Georges University Hospital Foundation Trust, UK
c Breast Screening Programme, Public Health England, London, UK
d Cambridge Breast Unit, NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals NHS Trust, UK
article in formation
AIM: To examine the association between recall, needle biopsy, and cancer detection rates to inform the setting of target ranges to optimise the benefit to harm ratio of breast screening programmes.
MATERIALS AND METHODS: Annual screening programme information from 2009/10 to 2015/16 for the 80 screening units of the English National Health Service Breast Screening Programme (totalling 11.3 million screening tests) was obtained from annual (KC62) returns. Linear regression models were used to examine the association between needle biopsy rates and recall rates and non-linear regression models to examine the association between cancer detection rates and needle biopsy rates.